CD160 and hepatocellular carcinoma: 3.1.2. Decrease of CD160+Siglec-7+CD49a-CD56dimNK Cells and Increase of CD160-Siglec-7-CD49a+CD56dimNK Cells with Siglec-10, ILT2 and PD-1 Expression in the Peripheral Blood of HCC Patients